Keywords : Budesonide
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 2, Pages 1760-1766
Abstract: In recent years, serious and numerous advances have been made in the treatment
of bronchial asthma. These results are associated with the significant efficacy of inhaled
corticosteroids in topical diagnosis and pathogenetic treatment of bronchial asthma.
However, despite the results achieved, the fight against this disease is not satisfactory. In
patients with severe bronchial asthma, inhaled corticosteroids are more effective when
used in combination with β2-agonists. Almost every second asthma patient is concerned
about nighttime attacks. More than half of the patients had limited physical activity, and
one in three lost the ability to work. Most patients are forced to see a doctor because of the
exacerbation and progression of the disease.